| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |